GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC)
Clinical trial NCT04648917 · UNKNOWN
Trial details
- NCT number
- NCT04648917
- Sponsor
- The First Affiliated Hospital of Henan University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2021-05-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.